On October 9, Guangdong released an action plan for further promoting the high-quality development of the province's biopharmaceutical industry, proposing 38 key tasks and initiatives themed around innovative mechanisms, product upgrading, industry clustering, and business environment creation.

According to the action plan, Guangdong will strive to achieve a biopharmaceutical and health industry cluster exceeding RMB 1 trillion in scale by 2027, with an above-scale pharmaceutical industry exceeding RMB 500 billion.

For Guangdong-based biopharmaceutical enterprises, what opportunities will the release of the action plan bring to industrial development? How do they evaluate the unique advantages and business environment of Guangdong's biopharmaceutical industry? Let's take a look.

(cnbayarea.org.cn & GDToday)